⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GRFS News
Grifois, S.A.
Von Willebrand Disease Treatment Market Size to be Valued at USD 4.70 Billion by 2035 Owing to the Increasing Awareness Globally | SNS Insider
globenewswire.com
CSL
GRFS
Buminate Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
GRFS
Koate-DVI Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
GRFS
Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight
globenewswire.com
VNDA
GRFS
BHC
RDHL
MRK
TEVA
PFE
SNY
LLY
ABBV
AZN
CRCT
SPRO
CRNX
Kawasaki Disease Market Analysis and Global Forecast Report 2025-2035 Featuring Prominent Players - Takeda Pharmaceutical, CSL Behring, Grifols, ADMA Biologics, and Octapharma
globenewswire.com
CSL
GRFS
ADMA
World Hemophilia Day 2026 - April 17, 2026 - "Diagnosis: First step to care." USA - English India - English
prnewswire.com
BMRN
CSL
GRFS
NVO
PFE
REGN
SAN
TAK
Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates
globenewswire.com
GRFS
Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson’s Disease
globenewswire.com
GRFS
Health Coalition demands disclosures & end to Grifols’ for-profit blood plasma contract following reports of deaths, harm, non-compliance
globenewswire.com
GRFS
Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols’ Sites
globenewswire.com
GRFS